Candesartan vs losartan and mortality in patients with heart failure

JAMA. 2011 Apr 20;305(15):1540-1; author reply 1541-2. doi: 10.1001/jama.2011.462.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Biphenyl Compounds
  • Europe
  • Guideline Adherence
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Losartan / therapeutic use*
  • Registries
  • Sweden / epidemiology
  • Tetrazoles / therapeutic use*
  • Ventricular Dysfunction, Left

Substances

  • Angiotensin Receptor Antagonists
  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • Losartan
  • candesartan